Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Lars Dyrskjøt, Søren Vang et al.|Cancer Cell|2016Cited by 654
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBernard Escudier, Vesa Kataja, Tim Eisen et al.|Annals of Oncology|2012Cited by 275
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Torben F. Ørntoft, Thomas Reinert et al.|European Urology|2017Cited by 100
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E.M. van Kessel, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|Clinical Cancer Research|2018Cited by 92
Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary TumoursMoniek M. Vedder, Ewout W. Steyerberg, Mirari Márquez et al.|PLoS ONE|2014Cited by 66